Would a drug for dementia that produced modest improvement be worth using, despite side effects? Carers’ views contrast sharply with those of professionals on this question, as Antony Bayer’s research showed.
Author/s: Antony Bayer
For the full article please see the PDF download linked to the right. The full JDC archive is available if you subscribe.